| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Aug 2025 | 1 Aug 2025 |
| Veerhealth Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve 1. Unaudited financial results of the Company for the quarter ended 30th June 2025. 2. Draft Directors Report for the financial year ending 31st March 2025. 3. Draft notice convening 33rd Annual General Meeting of the Company. | ||
| Board Meeting | 30 May 2025 | 21 May 2025 |
| Final Dividend & Audited Results The Board has not recommended any dividend on equity shares of the Company for the financial year ended March 31, 2025. Intimation under Regulation 30. (As Per BSE Announcement Dated on :30.05.2025) | ||
| Board Meeting | 12 Feb 2025 | 4 Feb 2025 |
| Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve unaudited financial results of the Company for the quarter and nine months ended 31st December 2024. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about outcome of the Meeting of Board of Directors of the Company held today i.e. February 12, 2025 as under: 1. The Board has approved and taken on record the unaudited financial results for the quarter and nine months ended December 31, 2024. The Board Meeting commenced at 4.00 p.m. and concluded at 4.40 p.m. Pursuant to Regulation 33 of the SEBI (LODR) Regulations, 2015, we enclose the following: 1. Statement showing unaudited financial results for the quarter and nine months ended December 31, 2024. 2. Limited Review Report on unaudited financial results for the quarter and nine months ended December 31, 2024. (As Per BSE Announcement Dated on 12/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 6 Nov 2024 |
| Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Unaudited financial results of the Company for the quarter and half year ended 30th September 2024. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you about the outcome of the Meeting of the Board of Directors of the Company held today i.e. November 14, 2024 as under: 1. The Board has approved and taken on record the unaudited financial results for the quarter and half year ended September 30, 2024. The Board Meeting commenced at 4.00 p.m. and concluded at 5.00 p.m. (As per BSE Announcement Dated on 14/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.